SCHEMBL3846080

SCHEMBL3846080

CS(=O)(=O)c1ccc(F)c(N2CCN(c3ncnc4ccc(Br)cc34)CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.58
ALDH1A1 P00352 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
PDGFRB P09619 4/20 0.43
ACHE P22303 2/20 0.42
BACE1 P56817 2/20 0.42
GBA1 P04062 1/20 0.41
RAB9A P51151 1/20 0.41
CYP3A4 P08684 4/20 0.41
LMNA P02545 3/20 0.41
CYP1A2 P05177 3/20 0.41
MAPK1 P28482 3/20 0.41
CLK4 Q9HAZ1 3/20 0.41
HIF1A Q16665 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ENPP1 P22413 1/20 0.41
CYP2D6 P10635 1/20 0.39
HTR6 P50406 1/20 0.39
USP2 O75604 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846794 0.81 HTT (0.58) HTTALDH1A1NPSR1PDGFRBACHE
SCHEMBL3856238 0.81 HTT (0.60) HTTALDH1A1NPSR1PDGFRBACHE
Hydrochloric Acid SCHEMBL3850590 0.80 AKT1 (0.49) ALDH1A1PDGFRBCYP3A4LMNACYP1A2
SCHEMBL30734224 0.80 HTT (0.64) HTTALDH1A1NPSR1PDGFRBACHE
SCHEMBL3848366 0.78 HTT (0.57) HTTALDH1A1NPSR1PDGFRBACHE
SCHEMBL3852227 0.76 CYP3A4 (0.42) ALDH1A1GBA1RAB9ACYP3A4LMNA
SCHEMBL3845658 0.76 CHRM4 (0.56) HTTALDH1A1NPSR1PDGFRBENPP1
SCHEMBL4349956 0.74 HTT (1.00) HTTALDH1A1NPSR1ACHEBACE1
SCHEMBL31745386 0.73 HTT (0.64) HTTALDH1A1NPSR1PDGFRBACHE
SCHEMBL22715242 0.73 HTT (0.76) HTTALDH1A1NPSR1PDGFRBACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed